Bring Them On: China Releases Generics List To Encourage Competition
China's National Health Commission issues list of 34 generic drugs that have 'insufficient' competition, seeking public comments.
You may also be interested in...
Strides Fast-Tracks China Entry With JV As It Reports Strong Q1
Indian firm Strides announces its entry into China through a joint venture with one of the country’s leading pharmaceutical firms, as first-quarter EBITDA soars 155%.
Cipla Docks Into China, Manufacturing Plans In Tow
More Indian companies are headed to China, with Cipla the latest to seal a joint venture there, though the firm has previous links with the country. Respiratory products will lead Cipla’s line-up in China, a market seen as a crucial cog in the firm’s future road map.
China Ho! Sun Strikes Deals For Ilumya, Cequa
India's Sun has licensed out treatments for psoriasis and dry eye to a new partner for selected Asian markets and China, which it expects to emerge as a key market for its products.